APO Research

APO RESEARCH · REPORT

Vinpocetine

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Product & engineering

Understand the product.

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).

Selected research

Industry Growth & Trends

Global Vinpocetine Industry Growth and Trends Forecast to 2032

Market perspective

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).

In the US market, the major manufacturers are Gedeon Richter, Runhong, Sun Pharma, WZT, Pude, Welman and Zhitong.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Vinpocetine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vinpocetine market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vinpocetine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vinpocetine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vinpocetine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vinpocetine Market by Company

Gedeon Richter

Runhong

Sun Pharma

WZT

PUDE

Welman

ZhiTong

Liaoning Zhiying

COVEX

Northeast Pharma

Micro Labs

Vinpocetine Segment by Type

Tablet

Injection

Vinpocetine Segment by Application

Household

Hospital

Vinpocetine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinpocetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vinpocetine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinpocetine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vinpocetine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vinpocetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Injection Table 3. Global Vinpocetine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Vinpocetine Sales by Type (2021-2026) & (M Units) Table 5. Global Vinpocetine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Vinpocetine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Vinpocetine Sales Market Share in Value by Type (2021-2026) Table 8. Global Vinpocetine Price by Type (2021-2026) & (USD/Unit) Table 9. Global Vinpocetine Sales by Type (2027-2032) & (M Units) Table 10. Global Vinpocetine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Vinpocetine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Vinpocetine Sales Market Share in Value by Type (2027-2032) Table 13. Global Vinpocetine Price by Type (2027-2032) & (USD/Unit) Table 14. North America Vinpocetine Sales by Type (2021-2026) & (M Units) Table 15. North America Vinpocetine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Vinpocetine Sales by Type (2021-2026) & (M Units) Table 17. Europe Vinpocetine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Vinpocetine Sales by Type (2021-2026) & (M Units) Table 19. Asia-Pacific Vinpocetine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Vinpocetine Sales by Type (2021-2026) & (M Units) Table 21. Latin America Vinpocetine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Vinpocetine Sales by Type (2021-2026) & (M Units) Table 23. Middle East and Africa Vinpocetine Sales by Type (2021-2026) & (US$ Million) Table 24. Vinpocetine Industry Trends Table 25. Vinpocetine Industry Drivers Table 26. Vinpocetine Industry Opportunities and Challenges Table 27. Vinpocetine Industry Restraints Table 28. Global Vinpocetine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Vinpocetine Revenue Market Share by Company (2021-2026) Table 30. Global Vinpocetine Sales by Company (2021-2026) & (M Units) Table 31. Global Vinpocetine Sales Share by Company (2021-2026) Table 32. Global Vinpocetine Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Vinpocetine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Vinpocetine Major Company Production Sites and Headquarters Table 35. Global Vinpocetine Company, Product Type & Application Table 36. Global Vinpocetine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Vinpocetine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Vinpocetine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Vinpocetine Sales by Region (2021-2026) & (M Units) Table 41. Global Vinpocetine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Vinpocetine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Vinpocetine Sales Market Share in Value by Region (2021-2026) Table 44. Global Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Vinpocetine Sales by Region (2027-2032) & (M Units) Table 46. Global Vinpocetine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Vinpocetine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Vinpocetine Sales Market Share in Value by Region (2027-2032) Table 49. Global Vinpocetine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Vinpocetine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Vinpocetine Sales by Application (2021-2026) & (M Units) Table 52. Global Vinpocetine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Vinpocetine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Vinpocetine Sales Market Share in Value by Application (2021-2026) Table 55. Global Vinpocetine Price by Application (2021-2026) & (USD/Unit) Table 56. Global Vinpocetine Sales by Application (2027-2032) & (M Units) Table 57. Global Vinpocetine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Vinpocetine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Vinpocetine Sales Market Share in Value by Application (2027-2032) Table 60. Global Vinpocetine Price by Application (2027-2032) & (USD/Unit) Table 61. North America Vinpocetine Sales by Application (2021-2026) & (M Units) Table 62. North America Vinpocetine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Vinpocetine Sales by Application (2021-2026) & (M Units) Table 64. Europe Vinpocetine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Vinpocetine Sales by Application (2021-2026) & (M Units) Table 66. Asia-Pacific Vinpocetine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Vinpocetine Sales by Application (2021-2026) & (M Units) Table 68. Latin America Vinpocetine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Vinpocetine Sales by Application (2021-2026) & (M Units) Table 70. Middle East and Africa Vinpocetine Sales by Application (2021-2026) & (US$ Million) Table 71. Gedeon Richter Company Information Table 72. Gedeon Richter Business Overview Table 73. Gedeon Richter Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Gedeon Richter Vinpocetine Product Portfolio Table 75. Gedeon Richter Recent Development Table 76. Runhong Company Information Table 77. Runhong Business Overview Table 78. Runhong Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Runhong Vinpocetine Product Portfolio Table 80. Runhong Recent Development Table 81. Sun Pharma Company Information Table 82. Sun Pharma Business Overview Table 83. Sun Pharma Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Sun Pharma Vinpocetine Product Portfolio Table 85. Sun Pharma Recent Development Table 86. WZT Company Information Table 87. WZT Business Overview Table 88. WZT Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. WZT Vinpocetine Product Portfolio Table 90. WZT Recent Development Table 91. PUDE Company Information Table 92. PUDE Business Overview Table 93. PUDE Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. PUDE Vinpocetine Product Portfolio Table 95. PUDE Recent Development Table 96. Welman Company Information Table 97. Welman Business Overview Table 98. Welman Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Welman Vinpocetine Product Portfolio Table 100. Welman Recent Development Table 101. ZhiTong Company Information Table 102. ZhiTong Business Overview Table 103. ZhiTong Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. ZhiTong Vinpocetine Product Portfolio Table 105. ZhiTong Recent Development Table 106. Liaoning Zhiying Company Information Table 107. Liaoning Zhiying Business Overview Table 108. Liaoning Zhiying Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Liaoning Zhiying Vinpocetine Product Portfolio Table 110. Liaoning Zhiying Recent Development Table 111. COVEX Company Information Table 112. COVEX Business Overview Table 113. COVEX Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. COVEX Vinpocetine Product Portfolio Table 115. COVEX Recent Development Table 116. Northeast Pharma Company Information Table 117. Northeast Pharma Business Overview Table 118. Northeast Pharma Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Northeast Pharma Vinpocetine Product Portfolio Table 120. Northeast Pharma Recent Development Table 121. Micro Labs Company Information Table 122. Micro Labs Business Overview Table 123. Micro Labs Vinpocetine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Micro Labs Vinpocetine Product Portfolio Table 125. Micro Labs Recent Development Table 126. North America Vinpocetine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 127. North America Vinpocetine Sales by Country (2021-2026) & (M Units) Table 128. North America Vinpocetine Sales Market Share by Country (2021-2026) Table 129. North America Vinpocetine Sales Forecast by Country (2027-2032) & (M Units) Table 130. North America Vinpocetine Sales Market Share Forecast by Country (2027-2032) Table 131. North America Vinpocetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Vinpocetine Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Vinpocetine Market Share by Country (2021-2026) Table 134. North America Vinpocetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Vinpocetine Market Share Forecast by Country (2027-2032) Table 136. Europe Vinpocetine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 137. Europe Vinpocetine Sales by Country (2021-2026) & (M Units) Table 138. Europe Vinpocetine Sales Market Share by Country (2021-2026) Table 139. Europe Vinpocetine Sales Forecast by Country (2027-2032) & (M Units) Table 140. Europe Vinpocetine Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Vinpocetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Vinpocetine Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Vinpocetine Market Share by Country (2021-2026) Table 144. Europe Vinpocetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Vinpocetine Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Vinpocetine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Vinpocetine Sales by Country (2021-2026) & (M Units) Table 148. Asia-Pacific Vinpocetine Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Vinpocetine Sales Forecast by Country (2027-2032) & (M Units) Table 150. Asia-Pacific Vinpocetine Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Vinpocetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Vinpocetine Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Vinpocetine Market Share by Country (2021-2026) Table 154. Asia-Pacific Vinpocetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Vinpocetine Market Share Forecast by Country (2027-2032) Table 156. Latin America Vinpocetine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 157. Latin America Vinpocetine Sales by Country (2021-2026) & (M Units) Table 158. Latin America Vinpocetine Sales Market Share by Country (2021-2026) Table 159. Latin America Vinpocetine Sales Forecast by Country (2027-2032) & (M Units) Table 160. Latin America Vinpocetine Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Vinpocetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Vinpocetine Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Vinpocetine Market Share by Country (2021-2026) Table 164. Latin America Vinpocetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Vinpocetine Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Vinpocetine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Vinpocetine Sales by Country (2021-2026) & (M Units) Table 168. Middle East and Africa Vinpocetine Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Vinpocetine Sales Forecast by Country (2027-2032) & (M Units) Table 170. Middle East and Africa Vinpocetine Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Vinpocetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Vinpocetine Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Vinpocetine Market Share by Country (2021-2026) Table 174. Middle East and Africa Vinpocetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Vinpocetine Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Vinpocetine Distributors List Table 179. Vinpocetine Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Vinpocetine Image Figure 2. Global Vinpocetine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vinpocetine Market Size (2021-2032) & (US$ Million) Figure 4. Global Vinpocetine Sales (2021-2032) & (M Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (M Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (M Units) Figure 9. Global Vinpocetine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Vinpocetine Market Share by Type 2025 VS 2032 Figure 11. North America Vinpocetine Sales Market Share in Volume by Type in 2025 Figure 12. North America Vinpocetine Sales Market Share in Value by Type in 2025 Figure 13. Europe Vinpocetine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Vinpocetine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Vinpocetine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Vinpocetine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Vinpocetine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Vinpocetine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Vinpocetine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Vinpocetine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Vinpocetine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Household Image Figure 24. Global Household Sales YoY Growth (2021-2032) & (M Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (M Units) Figure 27. Global Vinpocetine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Vinpocetine Market Share by Application 2025 VS 2032 Figure 29. North America Vinpocetine Sales Market Share in Volume by Application in 2025 Figure 30. North America Vinpocetine Sales Market Share in Value by Application in 2025 Figure 31. Europe Vinpocetine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Vinpocetine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Vinpocetine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Vinpocetine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Vinpocetine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Vinpocetine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Vinpocetine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Vinpocetine Sales Market Share in Value by Application in 2025 Figure 39. North America Vinpocetine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 40. North America Vinpocetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Vinpocetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Vinpocetine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 44. Europe Vinpocetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Vinpocetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Vinpocetine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 48. Asia-Pacific Vinpocetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Vinpocetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Vinpocetine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 52. Latin America Vinpocetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Vinpocetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Vinpocetine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. Middle East and Africa Vinpocetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Vinpocetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Vinpocetine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Vinpocetine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Injection
Applications
  • Household
  • Hospital
Companies covered
  • Gedeon Richter
  • Runhong
  • Sun Pharma
  • WZT
  • PUDE
  • Welman
  • ZhiTong
  • Liaoning Zhiying
  • COVEX
  • Northeast Pharma
  • Micro Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vinpocetine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vinpocetine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vinpocetine Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Injection
  8. 1.4 Global Vinpocetine Market Size by Type
  9. 1.4.1 Global Vinpocetine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Vinpocetine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Vinpocetine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Vinpocetine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Vinpocetine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Vinpocetine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Vinpocetine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Vinpocetine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vinpocetine Industry Trends
  2. 2.2 Vinpocetine Industry Drivers
  3. 2.3 Vinpocetine Industry Opportunities and Challenges
  4. 2.4 Vinpocetine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vinpocetine Revenue (2021-2026)
  2. 3.2 Global Top Players by Vinpocetine Sales (2021-2026)
  3. 3.3 Global Top Players by Vinpocetine Price (2021-2026)
  4. 3.4 Global Vinpocetine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vinpocetine Major Company Production Sites & Headquarters
  6. 3.6 Global Vinpocetine Company, Product Type & Application
  7. 3.7 Global Vinpocetine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vinpocetine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vinpocetine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vinpocetine Tier 1, Tier 2, and Tier 3
4 Vinpocetine Regional Status and Outlook
  1. 4.1 Global Vinpocetine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vinpocetine Historic Market Size by Region
  3. 4.2.1 Global Vinpocetine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vinpocetine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vinpocetine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vinpocetine Forecasted Market Size by Region
  7. 4.3.1 Global Vinpocetine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vinpocetine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vinpocetine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vinpocetine by Application
  1. 5.1 Vinpocetine Market by Application
  2. 5.1.1 Household
  3. 5.1.2 Hospital
  4. 5.2 Global Vinpocetine Market Size by Application
  5. 5.2.1 Global Vinpocetine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Vinpocetine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Vinpocetine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Vinpocetine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Vinpocetine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Vinpocetine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Vinpocetine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Vinpocetine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Gedeon Richter
  2. 6.1.1 Gedeon Richter Company Information
  3. 6.1.2 Gedeon Richter Business Overview
  4. 6.1.3 Gedeon Richter Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Gedeon Richter Vinpocetine Product Portfolio
  6. 6.1.5 Gedeon Richter Recent Developments
  7. 6.2 Runhong
  8. 6.2.1 Runhong Company Information
  9. 6.2.2 Runhong Business Overview
  10. 6.2.3 Runhong Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Runhong Vinpocetine Product Portfolio
  12. 6.2.5 Runhong Recent Developments
  13. 6.3 Sun Pharma
  14. 6.3.1 Sun Pharma Company Information
  15. 6.3.2 Sun Pharma Business Overview
  16. 6.3.3 Sun Pharma Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharma Vinpocetine Product Portfolio
  18. 6.3.5 Sun Pharma Recent Developments
  19. 6.4 WZT
  20. 6.4.1 WZT Company Information
  21. 6.4.2 WZT Business Overview
  22. 6.4.3 WZT Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 WZT Vinpocetine Product Portfolio
  24. 6.4.5 WZT Recent Developments
  25. 6.5 PUDE
  26. 6.5.1 PUDE Company Information
  27. 6.5.2 PUDE Business Overview
  28. 6.5.3 PUDE Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 PUDE Vinpocetine Product Portfolio
  30. 6.5.5 PUDE Recent Developments
  31. 6.6 Welman
  32. 6.6.1 Welman Company Information
  33. 6.6.2 Welman Business Overview
  34. 6.6.3 Welman Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Welman Vinpocetine Product Portfolio
  36. 6.6.5 Welman Recent Developments
  37. 6.7 ZhiTong
  38. 6.7.1 ZhiTong Company Information
  39. 6.7.2 ZhiTong Business Overview
  40. 6.7.3 ZhiTong Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ZhiTong Vinpocetine Product Portfolio
  42. 6.7.5 ZhiTong Recent Developments
  43. 6.8 Liaoning Zhiying
  44. 6.8.1 Liaoning Zhiying Company Information
  45. 6.8.2 Liaoning Zhiying Business Overview
  46. 6.8.3 Liaoning Zhiying Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Liaoning Zhiying Vinpocetine Product Portfolio
  48. 6.8.5 Liaoning Zhiying Recent Developments
  49. 6.9 COVEX
  50. 6.9.1 COVEX Company Information
  51. 6.9.2 COVEX Business Overview
  52. 6.9.3 COVEX Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 COVEX Vinpocetine Product Portfolio
  54. 6.9.5 COVEX Recent Developments
  55. 6.10 Northeast Pharma
  56. 6.10.1 Northeast Pharma Company Information
  57. 6.10.2 Northeast Pharma Business Overview
  58. 6.10.3 Northeast Pharma Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Northeast Pharma Vinpocetine Product Portfolio
  60. 6.10.5 Northeast Pharma Recent Developments
  61. 6.11 Micro Labs
  62. 6.11.1 Micro Labs Company Information
  63. 6.11.2 Micro Labs Business Overview
  64. 6.11.3 Micro Labs Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Micro Labs Vinpocetine Product Portfolio
  66. 6.11.5 Micro Labs Recent Developments
7 North America by Country
  1. 7.1 North America Vinpocetine Sales by Country
  2. 7.1.1 North America Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vinpocetine Sales by Country (2021-2026)
  4. 7.1.3 North America Vinpocetine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vinpocetine Market Size by Country
  6. 7.2.1 North America Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vinpocetine Market Size by Country (2021-2026)
  8. 7.2.3 North America Vinpocetine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vinpocetine Sales by Country
  2. 8.1.1 Europe Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vinpocetine Sales by Country (2021-2026)
  4. 8.1.3 Europe Vinpocetine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vinpocetine Market Size by Country
  6. 8.2.1 Europe Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vinpocetine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vinpocetine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vinpocetine Sales by Country
  2. 9.1.1 Asia-Pacific Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vinpocetine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vinpocetine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vinpocetine Market Size by Country
  6. 9.2.1 Asia-Pacific Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vinpocetine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vinpocetine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vinpocetine Sales by Country
  2. 10.1.1 South America Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vinpocetine Sales by Country (2021-2026)
  4. 10.1.3 South America Vinpocetine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vinpocetine Market Size by Country
  6. 10.2.1 South America Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vinpocetine Market Size by Country (2021-2026)
  8. 10.2.3 South America Vinpocetine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vinpocetine Sales by Country
  2. 11.1.1 Middle East and Africa Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vinpocetine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vinpocetine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vinpocetine Market Size by Country
  6. 11.2.1 Middle East and Africa Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vinpocetine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vinpocetine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vinpocetine Value Chain Analysis
  2. 12.1.1 Vinpocetine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vinpocetine Production Mode & Process
  7. 12.2 Vinpocetine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vinpocetine Distributors
  10. 12.2.3 Vinpocetine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research